Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord
Biomaterials are being developed as therapeutics for spinal cord injury (SCI) that can stabilize and bridge acute lesions and mediate the delivery of transgenes, providing a localized and sustained reservoir of regenerative factors. For clinical use, direct injection of biomaterial scaffolds is pref...
Main Authors: | Arshia Ehsanipour, Mayilone Sathialingam, Laila M. Rad, Joseph de Rutte, Rebecca D. Bierman, Jesse Liang, Weikun Xiao, Dino Di Carlo, Stephanie K. Seidlits |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2021-03-01
|
Series: | APL Bioengineering |
Online Access: | http://dx.doi.org/10.1063/5.0035291 |
Similar Items
-
Plasticity of the Injured Spinal Cord
by: Nicolas Guérout
Published: (2021-07-01) -
Iron homeostasis in the injured spinal cord
by: Rathore, Khizr Iqbal
Published: (2010) -
Graphene oxide-composited chitosan scaffold contributes to functional recovery of injured spinal cord in rats
by: Bing Yang, et al.
Published: (2021-01-01) -
Plasticity of the injured human spinal cord: insights revealed by spinal cord functional MRI.
by: David W Cadotte, et al.
Published: (2012-01-01) -
Transcriptome Analysis Reveals the Effects of Troxerutin and Cerebroprotein Hydrolysate Injection on Injured Spinal Cords in Rats
by: Linbang Wang, et al.
Published: (2020-01-01)